Amantadine for Neuroenhancement in Acute Patients Study

Clinical trial NCT05479032 · UNKNOWN

Trial details

NCT number: NCT05479032
Sponsor: University Hospital Tuebingen
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Disorder of Consciousness

Start date: 2023-03-01
Primary completion: 2024-10-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.